Nuvectis Pharma share price logo

Nuvectis Pharma

NASDAQ: NVCT

Small Cap

$21.92

-1.43

(-6.12%)

as on

Nuvectis Pharma Stock Performance

as on September 16, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $21.78
    $23.01
    downward going graph

    0.64%

    Downside

    4.97%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.55
    $29.28
    downward going graph

    74.68%

    Downside

    33.55%

    Upside

    downward going graph

Nuvectis Pharma share price movements today

Previous Close
$23.35
Open
$23.01
Volume
199.6K
Market Cap
$783.1M
Day's Low - High
$21.78 - $23.01
52 Week Low - High
$5.55 - $29.28

Nuvectis Pharma Historical Returns

1 Month Return
+ 23.15 %
3 Month Return
+ 109.42 %
1 Year Return
+ 277.22 %
3 Year Return
+ 60.15 %
5 Year Return
0 %

Nuvectis Pharma Stock Fundamentals & Key Indicators

Check Nuvectis Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$783.1M

EPS (TTM)

-1.31

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-14.68

Industry PE ratio

-6.33

PEG Ratio

0.9841486740302923

EBITDA

-28.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-169.47%

Nuvectis Pharma Stock Valuation

Track how Nuvectis Pharma P/E has moved over time to understand its valuation trends.

Nuvectis Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-5.83x)

December 31, 2023

Industry (-6.33x)

December 31, 2025

Today (-5.72x)

December 31, 2025

Highest (-3.21x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -5.72x

Nuvectis Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nuvectis Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$783.1MNA-14.680.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Stock Returns calculator for Nuvectis Pharma Stock including INR - Dollar returns

The Nuvectis Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Nuvectis Pharma investment value today

Current value as on today

₹3,86,585

Returns

₹2,86,585

(+286.58%)

Returns from Nuvectis Pharma Stock

₹2,54,120 (+254.12%)

Dollar Impact

₹32,465 (+32.47%)

Analyst Recommendation on Nuvectis Pharma Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Nuvectis Pharma. Average target price of $35.4

Nuvectis Pharma Share Price Target

Get share price movements and forecasts by analysts on Nuvectis Pharma.

What analysts predicted

38.08%UPSIDE

Target Price

$35.4

Current Price

$21.92

Analyzed by

5 Analysts

Target

$35.40

Nuvectis Pharma target price $35.4, a slight upside of 38.08% compared to current price of $21.92. According to 5 analysts rating.

Indian Investors' Interest in Nuvectis Pharma Stock

Search interest for Nuvectis Pharma Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-41% versus previous 30 day period

Nuvectis Pharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-4
-4
-4
-6
-5
-6
-7
-7
-6
-7
EBITDA
-4
-4
-4
-6
-5
-6
-7
-8
-6
-7
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-4
-4
-4
-6
-5
-6
-7
-7
-6
-7
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-4
-4
-4
-6
-5
-6
-7
-7
-6
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Nuvectis Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
0
-12
-19
-22
-19
-27
EBITDA
0
-12
-19
-22
-19
-26
Interest Expense
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
Income Before Tax
0
-12
-19
-22
-19
-26
Income Tax Expense
-
-
-
-
-
-
Net Income
0
-12
-19
-22
-19
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Nuvectis Pharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-4
-4
-6
-5
-6
-9
-7
-6
-7
Operating Cash Flow
-4
-3
-2
-2
-4
-3
-4
-3
-6
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
4
1
1
3
15
0
13
0
0
1
Change in Cash
0
-1
0
1
11
-3
8
-3
-6
-2

Nuvectis Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-12
-19
-22
-19
-26
Operating Cash Flow
-
-9
-13
-15
-12
-16
Investing Cash Flow
-
-
-
-
-
-
Financing Cash Flow
-
15
27
15
11
29
Change in Cash
-
5
14
0
0
13

Mutual Funds that own Nuvectis Pharma Stock

Check out the Mutual Funds with significant holdings in Nuvectis Pharma.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.989868%
649574
Fidelity Salem Street Trust
0.501787%
163804
Fidelity Concord Street Trust
0.47003%
153437
VANGUARD SCOTTSDALE FUNDS
0.282002%
92057
SCHWAB CAPITAL TRUST
0.152079%
49645

Global Institutional Holdings in Nuvectis Pharma

Funds
Holdings
Joseph Edelman
3.06%
Vanguard
2.96%
iShares
2.17%
Fidelity
0.3%
SPDR
0.13%

Nuvectis Pharma News & Key Events

  • img

    Today's Timeline - 29 June

    Tue, 01:31 AM

    -

    Nuvectis Pharma announces proposed public offering of common stock to advance development programs and corporate purposes.

    Tue, 08:00 AM

    -

    Nuvectis Pharma prices $100 million public offering of 5 million shares at $20 each, with additional shares option for underwriters.

Insights on Nuvectis Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NVCT stock has moved up by 15.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NVCT has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 478.8% return, outperforming this stock by 225.8%

About Nuvectis Pharma

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
OrganisationNuvectis Pharma
Headquarters1 Bridge Plaza, Fort Lee, NJ, United States, 07024
IndustryBiotechnology
CEOMr. Ron Bentsur M.B.A.
E-voting on sharesClick here to vote

Key Management of Nuvectis Pharma

Name

Title

Mr. Shay Shemesh

Co-Founder, Executive VP, Chief Development & Operations Officer

Mr. Michael Carson CPA

Vice President of Finance

Mr. Ron Bentsur M.B.A.

Co-Founder, Chairman, CEO & President

Dr. Enrique Poradosu Ph.D.

Co-Founder, Executive VP, Chief Scientific & Business Officer

FAQs

What is Nuvectis Pharma share price today?

Nuvectis Pharma share price today is $21.92 as on at the close of the market. Nuvectis Pharma share today touched a day high of $23.01 and a low of $21.78.

What is the 52 week high and 52 week low for Nuvectis Pharma share?

Nuvectis Pharma share touched a 52 week high of $29.28 on and a 52 week low of $5.55 on . Nuvectis Pharma stock price today i.e. is closed at $21.92,which is 25.12% down from its 52 week high and 294.95% up from its 52 week low.

What is Nuvectis Pharma's market capitalisation today?

Nuvectis Pharma market capitalisation is $0.00T as on .

How to invest in Nuvectis Pharma Stock (NVCT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nuvectis Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nuvectis Pharma Shares that will get you 0.0684 shares as per Nuvectis Pharma share price of $21.92 per share as on September 16, 2026 at 8:45 am IST.

What is the minimum amount required to buy Nuvectis Pharma Stock (NVCT) from India?

Indian investors can start investing in Nuvectis Pharma (NVCT) shares with as little as ₹95.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.40 in Nuvectis Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Nuvectis Pharma share’s latest price of $21.92 as on September 16, 2026 at 8:45 am IST, you will get 0.4562 shares of Nuvectis Pharma. Learn more about fractional shares .